The DOI matches its Crossref record; 59 of the 61 references it cites were found in a registry or an index.
Inhibition of CNS Remyelination by the Presence of Semaphorin 3A
Open accessAbstract
Failure of oligodendrocyte precursor cell (OPC) differentiation has been recognized as the leading cause for the failure of myelin regeneration in diseases such as multiple sclerosis (MS). One explanation for the failure of OPC differentiation in MS is the presence of inhibitory molecules in demyelinated lesions. So far only a few inhibitory substrates have been identified in MS lesions. Semaphorin 3A (Sema3A), a secreted member of the semaphorin family, can act as repulsive guidance cue for neuronal and glial cells in the CNS. Recent studies suggest that Sema3A is also expressed in active MS lesions. However, the implication of Sema3A expression in MS lesions remains unclear as OPCs are commonly present in chronic demyelinated lesions. In the present study we identify Sema3A as a potent, selective, and reversible inhibitor of OPC differentiation in vitro. Furthermore, we show that administration of Sema3A into demyelinating lesions in the rat CNS results in a failure of remyelination. Our results imply an important role for Sema3A in the differentiation block occurring in MS lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since the efficiency of remyelination is inversely correlated with lesion size, this model is advantageous for studying the kinetics of CNS remyelination36.”
From Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system (2016) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6.
Serafini, T., Kennedy, T. E., Gaiko, M. J., Mirzayan, C., Jessell, T., & Tessier-Lavigne, M. (1994) · Cell · doi:10.1016/0092-8674(94)90420-0 · Cited by 1,397
Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration
Fournier, A. E., GrandPré, T., & Strittmatter, S. M. (2001) · Nature · doi:10.1038/35053072 · Cited by 1,086
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 891
Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS
Filbin, M. T. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1195 · Cited by 873
Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation
Kotter, M. R., Li, W.-W., Zhao, C., & Franklin, R. J. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2615-05.2006 · Cited by 768
Self-citationNG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions
Chang, A., Nishiyama, A., Peterson, J. W., Prineas, J. W., & Trapp, B. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06404.2000 · Cited by 711
Notch Receptor Activation Inhibits Oligodendrocyte Differentiation
Wang, S., Sdrulla, A. D., diSibio, G., Bush, G., Nofziger, D., Hicks, C. D., Weinmaster, G., & Barres, B. A. (1998) · Neuron · doi:10.1016/s0896-6273(00)80515-2 · Cited by 706
Cited by
Sorted by citations
Myelination of the Nervous System: Mechanisms and Functions
Nave, K.-A., & Werner, H. B. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013101 · Cited by 983
Self-citationMyelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes‐Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 799
Oligodendrocyte Development and PlasticityPreprint
Bergles, D. E., & Richardson, W. D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020453 · Cited by 604
Semaphorins and their Signaling Mechanisms
Alto, L. T., & Terman, J. R. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6448-2_1 · Cited by 439
Boyd, A. L., Zhang, H., & Williams, A. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1112-y · Cited by 298
Remyelination therapies: a new direction and challenge in multiple sclerosis
Plemel, J. R., Liu, W., & Yong, V. W. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.115 · Cited by 293
Myelin damage and repair in pathologic CNS: challenges and prospects
Alizadeh, A., Dyck, S. M., & Karimi‐Abdolrezaee, S. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00035 · Cited by 246
Glial Development: The Crossroads of Regeneration and Repair in the CNS
Gallo, V., & Deneen, B. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.010 · Cited by 232
Natrajan, M. S., de la Fuente, A. G., Crawford, A. H., Linehan, E., Núñez, V., Johnson, K. R., Wu, T., Fitzgerald, D. C., Ricote, M., Bielekova, B., et al. (2015) · Brain · doi:10.1093/brain/awv289 · Cited by 225
Keough, M. B., Rogers, J. A., Zhang, P., Jensen, S. K., Stephenson, E. L., Chen, T., Hurlbert, M. G., Lau, L. W., Rawji, K. S., Plemel, J. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11312 · Cited by 217
Glia Disease and Repair—RemyelinationPreprint
Franklin, R. J. M., & Goldman, S. A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020594 · Cited by 217
Remyelination after spinal cord injury: Is it a target for repair?
Plemel, J. R., Keough, M. B., Duncan, G. J., Sparling, J. S., Yong, V. W., Stys, P. K., & Tetzlaff, W. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.006 · Cited by 206
Enhancing remyelination in disease--can we wrap it up?
Kotter, M., Stadelmann, C., & Hartung, H. ‐. (2011) · Brain · doi:10.1093/brain/awr014 · Cited by 182
Self-citationExtracellular matrix abnormalities in schizophrenia
Berretta, S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.010 · Cited by 179
Oligodendrogenesis in the normal and pathological central nervous system
Waly, B. E., Macchi, M., Cayre, M., & Durbec, P. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00145 · Cited by 193
Hota, P. K., & Buck, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1019-0 · Cited by 170
Cunha, M. I., Su, M., Cantuti-Castelvetri, L., Müller, S. A., Schifferer, M., Djannatian, M., Alexopoulos, I., van der Meer, F., Winkler, A., van Ham, T. J., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191390 · Cited by 160
The translational biology of remyelination: past, present, and future
Franklin, R. J. M., & Gallo, V. (2014) · Glia · doi:10.1002/glia.22622 · Cited by 162
Demyelination as a rational therapeutic target for ischemic or traumatic brain injury
Shi, H., Hu, X., Leak, R. K., Shi, Y., An, C., Suenaga, J., Chen, J., & Gao, Y. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.017 · Cited by 159
Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases
Jha, M. K., Kim, J.-H., Song, G. J., Lee, W., Lee, I. K., Lee, H., An, S. S. A., Kim, S., & Suk, K. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.12.003 · Cited by 156
Semaphorins in Adult Nervous System Plasticity and Disease
Carulli, D., de Winter, F., & Verhaagen, J. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.672891 · Cited by 137
Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ
Pendleton, J. C., Shamblott, M. J., Gary, D. S., Belegu, V., Hurtado, A., Malone, M. L., & McDonald, J. W. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.04.003 · Cited by 143
Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
Girolamo, F., Coppola, C., Ribatti, D., & Trojano, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0084-z · Cited by 127
Tepavčević, V., & Lubetzki, C. (2022) · Brain · doi:10.1093/brain/awac307 · Cited by 115
Lin, P.-C., Chan, P. M., Hall, C., & Manser, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.283580 · Cited by 106
Oligodendrocytes: Myelination, Plasticity, and Axonal SupportPreprint
Simons, M., Gibson, E. M., & Nave, K. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041359 · Cited by 110
Self-citationZhang, J., Zhang, Z. G., Li, Y., Ding, X., Shang, X., Lü, M., Elias, S. B., & Chopp, M. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.01.006 · Cited by 97
Boulanger, J. J., & Messier, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.063 · Cited by 93
The logistics of myelin biogenesis in the central nervous system
Snaidero, N., & Simons, M. (2017) · Glia · doi:10.1002/glia.23116 · Cited by 96
Giusto, E., Donegà, M., Cossetti, C., & Pluchino, S. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.009 · Cited by 92
Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury
Alizadeh, A., & Karimi‐Abdolrezaee, S. (2016) · The Journal of Physiology · doi:10.1113/jp270895 · Cited by 93
Chamberlain, K. A., Nanescu, S. E., Psachoulia, K., & Huang, J. K. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.010 · Cited by 97
Su, Y., Wang, X., Yang, Y., Chen, L., Xia, W., Hoi, K. K., Li, H. Z., Wang, Q., Yu, G., Chen, X., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.032 · Cited by 85
Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system
Gonzalez, G. A., Hofer, M. P., Syed, Y. A., Amaral, A. I., Rundle, J., Rahman, S., Zhao, C., & Kotter, M. R. N. (2016) · Scientific Reports · doi:10.1038/srep31599 · Cited by 86
“Demyelinated lesions were induced bilaterally by stereotactic injection of EB (0.01%, 4 ml) into the caudal cerebellar peduncle, − 10.4 mm caudal, ± 2.6 mm lateral, and − 7.3 mm ventral from bregma 36,37 .”
BackgroundMethodInfluentialSelf-citationRemyelination Therapy in Multiple Sclerosis
Harlow, D. E., Honce, J. M., & Miravalle, A. A. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00257 · Cited by 89
Dysregulation of CRMP2 Post-Translational Modifications Drive Its Pathological Functions
Moutal, A., White, K. A., Chefdeville, A., Laufmann, R. N., Vitiello, P. F., Feinstein, D. L., Weimer, J. M., & Khanna, R. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1568-4 · Cited by 78
Extracellular cues influencing oligodendrocyte differentiation and (re)myelination
Wheeler, N. A., & Fuss, B. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.03.019 · Cited by 80
A perspective on the role of class III semaphorin signaling in central nervous system trauma
Mecollari, V., Nieuwenhuis, B., & Verhaagen, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00328 · Cited by 79
Semaphorins and Plexins in central nervous system patterning: the key to it all?
Limoni, G., & Niquille, M. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.12.014 · Cited by 61
Psenicka, M. W., Smith, B. C., Tinkey, R. A., & Williams, J. L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.654284 · Cited by 73
Zveik, O., Rechtman, A., Ganz, T., & Vaknin‐Dembinsky, A. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00742-8 · Cited by 76
Kataria, H., Alizadeh, A., Shahriary, G. M., Rizi, S. S., Henrie, R., Santhosh, K. T., Thliveris, J. A., & Karimi‐Abdolrezaee, S. (2017) · Glia · doi:10.1002/glia.23264 · Cited by 72
Genetic architecture of the structural connectome
Wainberg, M., Forde, N. J., Mansour, S., Kerrebijn, I., Medland, S. E., Hawco, C. S., & Tripathy, S. J. (2024) · Nature Communications · doi:10.1038/s41467-024-46023-2 · Cited by 67
Remyelinating Pharmacotherapies in Multiple Sclerosis
Bove, R. M., & Green, A. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0577-0 · Cited by 66
Remyelination Therapy for Multiple Sclerosis
Keough, M. B., & Yong, V. W. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0152-7 · Cited by 64
RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury
Xing, B., Li, H., Wang, H., Mukhopadhyay, D., Fisher, D. W., Gilpin, C. J., & Li, S. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.018 · Cited by 63
Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination
Bernard, F., Moreau‐Fauvarque, C., Heitz‐Marchaland, C., Zagar, Y., Dumas, L., Fouquet, S., Lee, X., Shao, Z., Mi, S., & Chédotal, A. (2012) · Glia · doi:10.1002/glia.22378 · Cited by 65
Syed, Y. A., Baer, A., Hofer, M. P., González, G. A., Rundle, J., Myrta, S., Huang, J. K., Zhao, C., Rossner, M. J., Trotter, M. W. B., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201303123 · Cited by 58
Self-citationMyelin Regeneration in Multiple Sclerosis: Targeting Endogenous Stem Cells
Huang, J. K., Fancy, S. P. J., Zhao, C., Rowitch, D. H., ffrench‐Constant, C., & Franklin, R. J. M. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0065-x · Cited by 57
Self-citationHypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis
Narayana, P. A., Zhou, Y., Hasan, K. M., Datta, S., Sun, X., & Wolinsky, J. S. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513495936 · Cited by 56
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions
Costa, C., Martínez-Sáez, E. A., Gutiérrez-Franco, A., Eixarch, H., Castro, Z., Aznar, A. O., y Cajal, S. R., Montalbán, X., & Espejo, C. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515599848 · Cited by 51
Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination
Syed, Y. A., Zhao, C., Mahad, D., Möbius, W., Altmann, F., Foss, F., Sentürk, A., Acker-Palmer, A., Lubec, G., Lilley, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1521-1 · Cited by 50
Self-citationMohan, H., Friese, A. I., Albrecht, S., Krumbholz, M., Elliott, C., Arthur, A. T., Menon, R., Farina, C., Junker, A., Stadelmann, C., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0168-9 · Cited by 50
Implications of white matter damage in amyotrophic lateral sclerosis
Zhou, T., Ahmad, T. K., Gozda, K., Truong, J. L., Kong, J., & Namaka, M. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7186 · Cited by 51
Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis
Eixarch, H., Gutiérrez-Franco, A., Montalbán, X., & Espejo, C. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.01.003 · Cited by 46
Tiane, A., Schepers, M., Riemens, R. J. M., Rombaut, B., Vandormael, P., Somers, V. A., Prickaerts, J., Hellings, N., van den Hove, D., & Vanmierlo, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03927-2 · Cited by 46
Haindl, M. T., Köck, U., Adzemovic, M. Z., Fazekas, F., & Hochmeister, S. (2018) · Glia · doi:10.1002/glia.23556 · Cited by 46
Sema4D as an inhibitory regulator in oligodendrocyte development
Yamaguchi, W., Tamai, R., Kageura, M., Furuyama, T., & Inagaki, S. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.12.004 · Cited by 43
MicroRNA-30b promotes axon outgrowth of retinal ganglion cells by inhibiting Semaphorin3A expression
Han, F., Huo, Y., Huang, C.-J., Chen, C.-L., & Ye, J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.014 · Cited by 43
de Jong, C. G. H. M., Gabius, H., & Baron, W. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03327-7 · Cited by 44
Gutiérrez-Franco, A., Costa, C., Eixarch, H., Castillo, M., Medina-Rodriguez, E. M., Bribián, A., de Castro, F., Montalbán, X., & Espejo, C. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.12.005 · Cited by 39
Remyelination in the central nervous system
Franklin, R. J. M., Bodini, B., & Goldman, S. A. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041371 · Cited by 40
Rinaldi, M., Thomas, L., Mathieu, P., Carabias, P., Troncoso, M. F., Pasquini, J. M., Rabinovich, G. A., & Pasquini, L. A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.003 · Cited by 38
The environment rules: spatiotemporal regulation of oligodendrocyte differentiation
Mayoral, S. R., & Chan, J. R. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.04.002 · Cited by 36
Ito, A., Wang, T., Nakahara, R., Kawai, H. D., Nishitani, K., Aoyama, T., & Kuroki, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234691 · Cited by 34
Redox regulation of cytoskeletal dynamics during differentiation and de-differentiation
Gellert, M., Hanschmann, E.-M., Lepka, K., Berndt, C., & Lillig, C. H. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.10.030 · Cited by 35
Macroglial diversity: white and grey areas and relevance to remyelination
Werkman, I. L., Lentferink, D. H., & Baron, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03586-9 · Cited by 33
CRISPR-edited human ES-derived oligodendrocyte progenitor cells improve remyelination in rodents
Wagstaff, L. J., Bestard-Cuche, N., Kaczmarek, M., Fidanza, A., McNeil, L., Franklin, R. J. M., & Williams, A. C. (2024) · Nature Communications · doi:10.1038/s41467-024-52444-w · Cited by 30
Lotfi, R., Kalmarzi, R. N., Rajabinejad, M., Hasani, S., & Zamani, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107556 · Cited by 31
Emerging role of semaphorin-3A in autoimmune diseases
Liu, L., Li, X., Ye, D., & Pan, H. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0484-y · Cited by 29
Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients
Rezaeepoor, M., Shapoori, S., Ganjalıkhani-Hakemi, M., Etemadifar, M., Alsahebfosoul, F., Eskandari, N., & Mansourian, M. (2017) · Gene · doi:10.1016/j.gene.2017.02.013 · Cited by 28
Class 3 semaphorins as a therapeutic target
Goshima, Y., Sasaki, Y., Yamashita, N., & Nakamura, F. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.710201 · Cited by 25
Schmidt, F., van den Eijnden, M., Gobert, R. P., Saborı́o, G. P., Carboni, S., Alliod, C., Pouly, S., Staugaitis, S. M., Dutta, R., Trapp, B. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040457 · Cited by 24
Remyelinating strategies in multiple sclerosis
Luessi, F., Kuhlmann, T., & Zipp, F. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.969241 · Cited by 24
Motavaf, M., Sadeghizadeh, M., & Javan, M. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0472-6 · Cited by 25
Current status of myelin replacement therapies in multiple sclerosis
Huang, J. K., & Franklin, R. J. M. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59544-7.00011-1 · Cited by 23
Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination
Galloway, D. A., Gowing, E., Setayeshgar, S., & Kothary, R. (2019) · Glia · doi:10.1002/glia.23711 · Cited by 23
Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
Packer, D., Fresenko, E. E., & Harrington, E. P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207007 · Cited by 21
Zhao, P., Wang, Y.-Q., Liu, X., Zhu, Y., Zhao, H., Zhang, Q., Qi, F., Li, J.-L., Zhang, N., Fan, Y., et al. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.02.014 · Cited by 21
Zuroff, L. R., Farkhondeh, V., Bove, R. M., & Green, A. (2025) · Drugs · doi:10.1007/s40265-025-02212-x · Cited by 20
Modelling and Refining Neuronal Circuits with Guidance Cues: Involvement of Semaphorins
Limoni, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116111 · Cited by 18
Embracing oligodendrocyte diversity in the context of perinatal injury
Cunningham, L. A., Newville, J., & Jantzie, L. L. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.217320 · Cited by 20
Berardino, B. G., Chertoff, M., Gianatiempo, O., Alberca, C. D., Priegue, R., Fiszbein, A., Long, P. T., Corfas, G., & Cánepa, E. T. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.03.027 · Cited by 17
Abi‐Ghanem, C., Jonnalagadda, D., Chun, J. J. M., Kihara, Y., & Ranscht, B. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.908401 · Cited by 16
Manipulating oligodendrocyte intrinsic regeneration mechanism to promote remyelination
Binamé, F., Pham-Van, L. D., & Bagnard, D. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03852-4 · Cited by 16
Recruitment of endogenous CNS stem cells for regeneration in demyelinating disease
Murphy, N. A., & Franklin, R. J. M. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.12.013 · Cited by 14
Roles of Semaphorins in Neurodegenerative Diseases
Quintremil, S., Ferrer, F. M., Puente, J., Pando, M. E., & Valenzuela, M. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82046 · Cited by 13
Demyelination and Remyelination in Multiple Sclerosis
Bø, L., Esiri, M. M., Evangelou, N., & Kuhlmann, T. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2218-1_2 · Cited by 11
ANGPTL2 binds MAG to efficiently enhance oligodendrocyte differentiation
Chen, L., Yu, Z., Xie, L., He, X., Mu, X., Chen, C., Yang, W., Tong, X., Liu, J., Gao, Z., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00970-3 · Cited by 9
GDE2 expression in oligodendroglia regulates the pace of oligodendrocyte maturation
Choi, B., Dobrowolski, M., & Sockanathan, S. (2020) · Developmental Dynamics · doi:10.1002/dvdy.265 · Cited by 10
Assessment of plasma biomarkers for their association with Multiple Sclerosis progression
Jacob, S. P., Al-Kandari, A., Alroughani, R., & Al-Temaimi, R. A. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.01.008 · Cited by 10
Studying the Effects of Semaphorins on Oligodendrocyte Lineage Cells
Syed, Y. A., Abdulla, S. A., & Kotter, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6448-2_26 · Cited by 8
Self-citationPromoting return of function in multiple sclerosis: An integrated approach
Gacias, M., & Casaccia, P. (2013) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2013.04.002 · Cited by 9
Hu, R., Shi, M., Xu, H., Wu, X., He, K., Chen, Y., Wu, L., & Ma, R. (2022) · PeerJ · doi:10.7717/peerj.13856 · Cited by 7
Endogenous Remyelination in the CNS
Franklin, R. J. M., Zhao, C., Lubetzki, C., & ffrench‐Constant, C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2218-1_4 · Cited by 7
Self-citationMoutal, A., Kalinin, S., Kowal, K., Marangoni, N., Dupree, J. L., Lin, S. X., Lis, K., Lisi, L., Hensley, K., Khanna, R., et al. (2019) · ASN NEURO · doi:10.1177/1759091419892090 · Cited by 7
The Role of Extracellular Matrix in Myelination and Oligodendrogenesis of the Central Nervous System
Khaksar, Z., Morovvati, H., Moradi, H. R., & Negah, S. S. (2019) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.7.2.66 · Cited by 6
Recent achievements in stem cell-mediated myelin repair
Jadasz, J. J., Lubetzki, C., Zalc, B., Stankoff, B., Hartung, H., & Küry, P. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000323 · Cited by 6
Functional Regeneration and Remyelination in the Zebrafish Optic Nerve
Zou, S., Wu, Y., Huang, Y., Tian, C., Ge, S., & Hu, B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801732-6.00002-1 · Cited by 5
Wang, C., & Kotter, M. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7862-5_18 · Cited by 5
Self-citation
Metadata
- Authors
- Syed, Y. A., Hand, E., Möbius, W., Zhao, C., Hofer, M., Nave, K. A., & Kotter, M. R.
- Affiliations
- University of Cambridge (GB)
- Max Planck Society (DE)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2011-03-09
- Volume
- 31
- Issue
- 10
- Pages
- 3719-3728
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6622776
- OpenAlex
- W2000180092
- Cited by
- 134
- References
- 61
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 8 · 2023: 8 · 2022: 4 · 2021: 9 · 2020: 5 · 2019: 10 · 2018: 5 · 2017: 11 · 2016: 10 · 2015: 18 · 2014: 13 · 2013: 9 · 2012: 9
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- semaphorin 3A, remyelination, oligodendrocyte precursor cells, oligodendrocyte differentiation, multiple sclerosis, demyelination, inhibitory molecules, demyelinating lesions
- MeSH terms
- Analysis of Variance, Animals, Animals, Newborn, Cell Differentiation, Female, Immunohistochemistry, Myelin Sheath, Nerve Regeneration, Oligodendroglia, Rats, Sprague-Dawley, In Situ Hybridization, Reverse Transcriptase Polymerase Chain Reaction, Semaphorin-3A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
